Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    I-RUX-15-04
Previous Study | Return to List | Next Study

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03110822
Recruitment Status : Recruiting
First Posted : April 12, 2017
Last Update Posted : May 2, 2019
Sponsor:
Collaborator:
Incyte Corporation
Information provided by (Responsible Party):
Oncotherapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2020
  Estimated Study Completion Date : August 2021